The U.S.s biggest manager of prescription drug benefits said it will cover a $1-a-capsule alternative to the anti-parasitic treatment Daraprim.

Pharmaceutical companies are pouring millions of dollars into an effort to head off a state ballot initiative that would rein in spending on medicine.

CVS quit selling tobacco products as part of a business decision to focus broadly on health care, and now says it may have helped in reducing smoking rates.

CVS officials want clearer guidelines about who needs the injectable cholesterol drug Praluent, one of a new class of drugs that has insurers and employers worried about costs.

The leading group of U.S. cancer doctors created a scoring system for oncology drugs, awarding a zero for overall benefit to the $9,200-a-month regimen featuring Eli Lilly & Co.s Alimta.